Introduction and objective. Temporomandibular disorders (TMD) are currently among the most commonly diagnosed disorders of the stomatognathic system. They are related to the overall condition of temporomandibular joints (TMJ). In recent years, there have been an increasing number of reports related to clinical patients suffering from stomatognathic disorders accompanying psoriasis. The aim of the study is to assess the incidence and identify the types of temporomandibular disorders in patients diagnosed with psoriasis. Materials and method. The study was conducted in a group of 64 patients (32 men and 32 women) treated for psoriasis at the Med-Laser Non-Public Health Care Centre in Lublin. The study was conducted in two stages. The first stage entailed the use of a normalised questionnaire in which the patients were surveyed regarding the incidence of TMD symptoms. The survey questions were prepared on the basis of the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/ TMD). The second stage entailed the performance of clinical examinations in accordance with the RDC/TMD classification guidelines. Results. The survey revealed that over 1/3 of the subjects experienced at least one type of TMJ disfunction included in the RDC/TMC questionnaire. Conclusions. Psoriasis patients are most often classified into class IIa TMD according to RDC / TMD diagnoses. For this reason, patients reporting such symptoms should be referred for full diagnostic stomatological examination for the possible presence of temporomandibular disorders. The inclusion of screening for TMD symptoms should be considered in patients treated for psoriasis.
INTRODUCTION
Temporomandibular disorders (TMD) are currently among the most commonly diagnosed disorders of the stomatognathic system. Pain originating from the joints of the stomatognathic system is the third, after dental caries and periodontal disease, the most common problem mentioned by patients reporting for stomatological treatment. Patients also very often report acoustic symptoms in the temporomandibular joints, mainly clicking or crackling sounds [1] . According to the relevant epidemiological studies, TMD symptoms are observed in approx. 60-80% of the population. As follows from the epidemiological data, pain associated with TMD affects approx. 9-13% of the population, including almost 50% more female than male patients. Symptoms are typically exacerbated in patients aged between 20-40 years and include: incorrect mandibular mobility (reduced or excessive range of motion), mandibular deviation (while opening or closing the jaw) acoustic symptoms in the temporomandibular joint (crackling, clicking), mandibular head skipping, and pain in the cephalic and facial region (joint and muscle pain). Accompanying symptoms can also include: pathological dentalgia, noncarious defects, gomphiasis (dental displacement), masseter muscle hypertrophy, morning stiffness of facial muscles, dental numbness and/or tingling, as well as symptoms in the visual and auditory systems, e.g. ear or eye pain, a sense of obstruction in the ears, tinnitus, vertigo, a sense of the eyeball bulging out of its socket, and lacrimation for no apparent reason. Disorders of the temporomandibular joint can also cause symptoms to occur in more distant regions of the body, e.g. spinal pain, lower back pain (sacralgia, lumbago), coxalgia, as well as knee or even ankle pain. 92% of all headaches treated as migraines originate from existing TMD.
Temporomandibular disorders have a complex aetiology. Both local and general factors seem to play a significant role in the same. The most commonly identified local causes include incorrect occlusion and parafunctional activity (e.g. clenching, clamping teeth together, compulsive biting down or chewing), while the most common general causes include stress and abnormal deep afferent impulsation.
Psoriasis is an inflammatory, non-contagious disease of a chronic and recurrent character. According to various sources, the incidence of psoriasis in the global adult population is estimated at approx. 1-3% [3] while the incidence in children is considerably less. Epidemiological data tend to vary significantly depending on the country as well as relative to geographical and racial factors. Psoriasis can occur at any age, although two peak periods can be identified in this respect -it most commonly occurs in young adults between 20-30 years of age, as well as in patients aged approx. 50-60.
The exact causes of psoriasis have yet to be clearly identified. Some research data suggest a genetic origin with a particular focus of the human leukocyte antigen (HLA) system. However, heredity is a multifaceted phenomenon and the emergence of the disease is conditional upon numerous complex processes that need to occur simultaneously. Research is also now being conducted with the aim of identifying immunological factors which may have an influence on the development and incidence of psoriasis, including the contribution of T lymphocytes and the mediators they produce. Various external and internal stimuli may also cause the onset of symptoms. These include physical (surgeries, tattooing, vaccinations, excoriations) as well chemical factors (chemical burns, cosmetics). Internal factors include: streptococcal pharyngitis, which often precedes the original dissemination in children and young adults, stress or HIV infection. It should be emphasised that exacerbation of the symptoms is commonly observed after chronic pharmacotherapy. This is most commonly observed in the case of broadly administered arterial hypertension drugs, e.g. beta adrenolytic [4] , as well as non-steroidal ant-inflammatory drugs (NSAIDs), often taken by patients without medical consultation.
The course of psoriasis can vary significantly between respective patients. The scalp is one of the most common locations [5] . Another area often affected by the disease is the intertriginous region (intragluteal cleft, groin, axilla, navel), which is due to the heat, moist, and continued irritation of the skin in those areas. The severity of skin lesions can be limited but they can also proliferate to significant areas of the skin, in many cases up to 90% of the skin area in conditions referred to as erythroderma. The first lesions are usually erythrodermic or plaque in character, often with accompanying silvery scaling. The lesions can cause itching, burning, or even pain. Traditionally, psoriasis was considered as a disease manifesting itself only externally; however, recent studies have revealed an increased incidence of serious cardiovascular disorders in patients diagnosed with psorias, compared to the general population [6] . A similar correlation was observed regarding the increased incidence of chronic kidney disease [7] . Furthermore, chronic psoriasis constitutes a serious psychological problem due to the difficult treatment, common relapses, as well as lack of social acceptance for skin lesions visible on the patient's skin, all of which increase the risk of depression [8] .
Psoriasis is usually categorised as one of two main types of psoriasis or psoriatic arthritis. Type 1 psoriasis usually develops in patients under the age of 40. It is believed to be strongly correlated with the HLA system, often occuring in members of the same family, and its course tends to be exacerbated to severe levels as the disease progresses. Type 2 psoriasis is usually diagnosed in patients over the age of 40. It is believed that it is not hereditary, has no strong correlations with the HLA system, and more commonly affects the areas of the nails and joints.
OBJECTIVE
The aim of the study was to assess the incidence and identify the types of TMD observed in patients diagnosed with psoriasis.
MATERIALS AND METHOD
The study was conducted in a group of 64 patients (32 men and 32 women) treated for psoriasis at the Med-Laser Non-Public Health Care Centre in Lublin between March -September 2018. The study group patients were aged between 13-66, with the mean age of 44 years and median of 46. 13 patients (20.31%) were between 13-29-years-old, 8 patients (12.3%) 30-39, 12 patients (18.75%) 40-49, 15 (23.44%) were 50-59, and 16 (25%) were 60-66-years-old. 59.38% of the patients were treated for type 1 cutaneous psoriasis, 10.94% for type 2 cutaneous psoriasis, and the remaining 29.69% of patients suffered from psoriatic arthritis. Inclusion criteria were: over 12 years of age (to avoid mixed dentition), psoriasis was the main disease and good mental state of the patient. Exclusion criteria were poor general condition of the patient and no desire to participate in the study.
The study consisted of two stages. The first stage entailed the use of a normalised questionnaire in which the patients were surveyed regarding the incidence of TMD symptoms. The survey questions were prepared on the basis of the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) [2] . The questions referred to: joint pain, muscle pain, incidence of acoustic symptoms, and functional disorders of the mandible. Patients were also surveyed in terms of the incidence of pain in the region of temporomandibular joints during the preceding month, reduced range of jaw mobility, clicking, crackling, teeth clenching at night, teeth clenching during the day, dental stiffness and/or pain in the morning, ringing or buzzing in the ears, occlusal discomfort, swelling, pain in joints other than TMJ, as well as incidence of headaches in the preceding 6 months.
The second stage of the study involved clinical examinations in accordance with the RDC/TMD classification guidelines. The intraoral clinical examination entailed a general dental examination and assessment of any prosthetics in terms of restoration of correct dental function. The functional clinical examination entailed: extraoral palpation of muscles in the stomatognathic, neck and shoulder girdle region, intraoral palpation of stomatognathic muscles, palpation of the lateral and distal regions of temporomandibular joint (TMJ), examination for audible symptoms and muscle pain during slow movements of the mandible, and a clinical analysis of mandibular mobility: range and sequence of abduction motion including any deviations, range and sequence of lateral motion, range and sequence of protrusion and retrusion, as well as potential dislocation of the TMJ articular disc on the basis of the observed acoustic symptoms, and diagnostic tests. All procedures performed the studies involving the participants were in accordance with the ethical standards of the Institutional and/or National Research Committee and with the 1964 Helsinki Declaration and its later amendments, or comparable ethical standards. The authors obtained the informed consent of patients/caregivers of patients to participate in the study.
The obtained results were processed and classified in accordance with the RDC/TMD classification guidelines. Statistical analysis of the results was conducted with the use of Fisher's test. The value of p<0.05 was adopted as the threshold of statistical significance.
RESULTS
The survey revealed that 37.5% of the analysed patients experienced at least one of the TMD symptoms included in the questionnaire. Pain in the TMJ region was reported by 17.19% of the respondents, 4 men and 7 women. Muscle pain and acoustic symptoms were reported by 4.69% of the patients, while mandibular mobility disorders were present in 3.13% of female respondents. 41.67% of patients experiencing TMD admitted that they needed treatment in this respect. 45.31% of the respondents reported having experienced headaches in the period of 6 months prior to the survey.
On the basis of the clinical study conducted in accordance with the RDC/TMD classification (Tab. 1), TMD was diagnosed in 9.37% of the patients, with class 2a diagnosed in 7.81% and 2b in 1.56% of the cases, while in the remaining 90.63% of the patients, TMD was not diagnosed. Figures 1  and 2 present the occurrence of TMD symptoms and selected risk factors in patients relative to the type of psoriasis and TMD diagnosis.
Almost half (43.75%) of the patients had complete alveolar arches or correct prosthetic restorations performed, the missing teeth in the remaining patients were either unrestored or the prosthetic restorations were found to be incorrect.
DISCUSSION
It has been estimated that between 1.3 to even 34.7% of patients diagnosed with psoriasis develop chronic arthritis (psoriatic arthritis), which can lead to significant articular deformations, and in extreme cases to disability. The disease usually takes the form of asymmetric inflammation of individual joints, typically distal digital joints. The affected digit becomes dactylitic, a state described as 'sausage fingers', while x-ray examinations produce the characteristic 'pencilin-cup' images. The disease can also extend to the knees, ankles, and spinal joints. In a study by Dervis and Dervis, it was reported that temporomandibular disorders did not occur more frequently in healthy patients compared to patients diagnosed with psoriasis. At the same time, they observed a high incidence of disorders in patients diagnosed with psoriatic arthritis (PA) [9] .
Numerous clinical cases have been reported in recent years where psoriatic patients also suffered from temporomandibular disorders. Okkesim et al. described the case of a patient diagnosed with psoriasis who struggled with pain and reduced mobility of the TMJ [10] . The performed x-ray (pantograph) with CBCT revealed foci of erosion and abnormal (rough) edges of the articular head surfaces. Similar erosion and osteoporotic lesions were revealed on the surface of the temporal bone. On this basis, psoriatic arthritis was diagnosed and standard TMD treatment was recommended, i.e. administration of NSAIDs and splint therapy. The symptoms subsided after one month of therapy. The authors emphasise a 5-8% risk of PA in patients diagnosed with psoriasis, which in turn can lead to TMD.
Loster reports the incidence of TMD in a group of young Polish adults at approx. 26.5% [11] . In the age group of students, the incidence of TMD was within the range from 15-68.6% [12] [13] [14] [15] [16] [17] , and in the group of adults it wa estimated at between 15-50.5% [18] [19] . The incidence of TMD in psoriasis patients is approx. 10%, which is significantly below the levels reported in literature for the general population. The discrepancy remains unexplained although it may be due to the fact that the incidence of TMD in the elderly population decreases is as low as 3-6% [20] [21] [22] , and that the mean age of the study group of patients was 44.
The symptoms most commonly reported by psoriasis patients diagnosed with TMD in accordance with RDC classification included: pain in the preceding month, reduced jaw mobility and headaches (over 80%) as well as clicking, crackling, clenching during the day (over 60%). Psoriasis patients without TMD most commonly reported headaches in the preceding 6 months, pain in the preceding month, as well as swelling, pain in joints other than TMJ (20-40%). Psoriasis patients diagnosed with TMD suffered -significantly more frequently than psoriasis patients without TMD -from: pain in the preceding month, reduced jaw mobility, clicking and crackling, as well as clenching during the day (Fig. 2) .
In own study, psoriasis patients were divided into 3 subgroups composed of patients suffering from: type 1 psoriasis, type 2 psoriasis, and psoriatic arthritis. Symptoms of TMJ disorders were most often observed in patients suffering from PA. Other commonly reported symptoms included pain in the preceding month and headache in the preceding 6 months (over 60%). A juxtaposition of the incidence of TMJ symptoms in the aforementioned three groups of psoriasis patients revealed a statistically significantly higher incidence of pain in the preceding month and clenching during the day in patients suffering from psoriatic arthritis, compared to type 1 psoriasis patients. In the group of patients with type 2 psoriasis, no statistically significant differences were observed, most likely due to the low number of patients in this group (Fig. 1 ). It seems that the described symptoms may be helpful in referring patients for dental examinations with a particular indication of possible TMD.
CONCLUSIONS
The incidence of TMD in examined psoriasis patients is approx. 10% and is lower than that reported in the general population. This can be attributed to the effects of psoriasis treatment received by the patients. Psoriasis patients are most often classified into class IIa TMD according to RDC/TMD diagnoses. For this reason, patients reporting such symptoms should be referred for full diagnostic stomatological examination for the possible presence of temporomandibular disorders.
The inclusion of screening for TMD symptoms should be considered in patients treated for psoriasis.
